A comprehensive review of the treatment of Merkel cell carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 6, 2007, Pages 624-636

  Eng, Tony Y ^a   Boersma, Melisa G ^a   Fuller, Clifton D ^a   Goytia, Virginia ^a   Jones III, William E ^a   Joyner, Melissa ^a   Nguyen, Dominic D ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Chemotherapy; Merkel cell carcinoma; Multimodality management; Radiation therapy; Surgery

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; CARBOPLATIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; IMATINIB; MITOXANTRONE; PLATINUM DERIVATIVE; PREDNISONE; VINCRISTINE;

AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BIOLOGY; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; HUMAN; LYMPH NODE DISSECTION; MERKEL CELL TUMOR; MOLECULAR GENETICS; POSTOPERATIVE CARE; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE; SUN EXPOSURE;

AGED; CARCINOMA, BASAL CELL; CARCINOMA, MERKEL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 37349072449     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318142c882     Document Type: Review

References (206)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107-110.
2. Frigerio B, Capella C, Eusebi V, et al. Merkel cell carcinoma of the skin: the structure and origin of normal Merkel cells. Histopathology. 1983;7:229-249.
3. Kivela T, Tarkkanen A. The Merkel cell and associated neoplasms in the eyelids and periocular region. Surv Ophthalmol. 1990;35:171-187.
4. Tachibana T, Nawa T. Recent progress in studies on Merkel cell biology. Anat Sci Int. 2002;77:26-33.
5. Haneke E. Electron microscopy of Merkel cell carcinoma from formalin-fixed tissue. J Am Acad Dermatol. 1985;12:487-492.
6. Szadowska A, Wozniak L, Lasota J, et al. Neuroendocrine (Merkel cell) carcinoma of the skin: a clinico-morphological study of 13 cases. Histopathology. 1989;15:483-493.
7. Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer. 1978;42:2311-2321.
8. Tang CK, Toker C. Trabecular carcinoma of the skin: further clinicopathologic and ultrastructural study. Mt Sinai J Med. 1979;46:516-523.
9. Brenner B, Sulkes A, Rakowsky E, et al. Second neoplasms in patients with Merkel cell carcinoma. Cancer. 2001;91:1358-1362.
10. Ratner D, Nelson BR, Brown MD, et al. Merkel cell carcinoma. J Am Acad Dermatol. 1993;29:143-156.
11. Goepfert H, Remmler D, Silva E, et al. Merkel cell carcinoma (endocrine carcinoma of the skin) of the head and neck. Arch Otolaryngol. 1984;110:707-712.
12. Cerroni L, Kerl H. Primary cutaneous neuroendocrine (Merkel cell) carcinoma in association with squamous- and basal-cell carcinoma. Am J Dermatopathol. 1997;19:610-613.
13. Gomez LG, DiMaio S, Silva EG, et al. Association between neuroendocrine (Merkel cell) carcinoma and squamous carcinoma of the skin. Am J Surg Pathol. 1983;7:171-177.
14. Aydin A, Kocer NE, Bekerecioglu M, et al. Cutaneous undifferentiated small (Merkel) cell carcinoma, that developed synchronously with multiple actinic keratoses, squamous cell carcinomas and basal cell carcinoma. J Dermatol. 2003;30:241-244.
15. Iacocca MV, Abernethy JL, Stefanato CM, et al. Mixed Merkel cell carcinoma and squamous cell carcinoma of the skin. J Am Acad Dermatol. 1998;39:882-887.
16. Popp S, Waltering S, Herbst C, et al. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer. 2002;99:352-360.
17. Hartschuh W, Schulz T. Merkel cell hyperplasia in chronic radiation-damaged skin: its possible relationship to fibroepithelioma of Pinkus. J Cutan Pathol. 1997;24:477-483.
18. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev. 1999;8:153-158.
19. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49:832-841.
20. Lunder EJ, Stern RS. Merkel cell carcinoma in patients treated with methoxsalen and ultraviolet radiation. N Engl J Med. 1998;339:1247-1248.
21. Howard RA, Dores GM, Curtis RE, et al. Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev. 2006;15:1545-1549.
22. Dong HY, Liu W, Cohen P, et al. B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in Merkel cell carcinoma and small cell carcinomas. Am J Surg Pathol. 2005;29:687-692.
23. Fernandez-Figueras MT, Puig L, Musulen E, et al. Expression profiles associated with aggressive behavior in Merkel cell carcinoma. Mod Pathol. 2007;20:90-101.
24. Koljonen V, Tukiainen E, Haglund C, et al. Cell cycle control by p21, p27 and p53 in Merkel cell carcinoma. Anticancer Res. 2006;26:2209-2212.
25. Kanitakis J, Euvrard S, Chouvet B, et al. Merkel cell carcinoma in organ-transplant recipients: report of 2 cases with unusual histological features and literature review. J Cutan Pathol. 2006;33:686-694.
26. Gooptu C, Woollons A, Ross J, et al. Merkel cell carcinoma arising after therapeutic immunosuppression. Br J Dermatol. 1997;137:637-641.
27. Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation. 1999;68:1717-1721.
28. Buell JF, Trofe J, Hanaway MJ, et al. Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34:1780-1781.
29. Baron JM, Sanchez C, Garcia P. Merkel cell carcinoma in a kidney transplant patient. Rev Clin Esp. 2001;201:223.
30. An KP, Ratner D. Merkel cell carcinoma in the setting of HIV infection. J Am Acad Dermatol. 2001;45:309-312.
31. Calza L, Beltrami C, Manfredi R, et al. Merkel cell carcinoma in a human immunodeficiency virus-infected patient. Br J Dermatol. 2002;146:895-898.
32. Engels EA, Frisch M, Goedert JJ, et al. Merkel cell carcinoma and HIV infection. Lancet. 2002;359:497-498.
33. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:315-323.
34. Hitchcock CL, Bland KI, Laney RG III, et al. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg. 1988;207:201-207.
35. Tuneu A, Pujol RM, Moreno A, et al. Postirradiation Merkel cell carcinoma. J Am Acad Dermatol. 1989;20:505-507.
36. Lardy F, Gautier C, Etesse-Pichon S, et al. Post-radiotherapy cutaneous neuro-endocrine carcinoma. Ann Dermatol Venereol. 1996;123:464-467.
37. Lien HC, Tsai TF, Lee YY, et al. Merkel cell carcinoma and chronic arsenicism. J Am Acad Dermatol. 1999;41:641-643.
38. Ho SY, Tsai YC, Lee MC, et al. Merkel cell carcinoma in patients with long-term ingestion of arsenic. J Occup Health. 2005;47:188-192.
39. Leonard JH, Leonard P, Kearsley JH. Chromosomes 1, 11, and 13 are frequently involved in karyotypic abnormalities in metastatic Merkel cell carcinoma. Cancer Genet Cytogenet. 1993;67:65-70.
40. Van Gele M, Leonard JH. Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma. Int J Cancer. 2002;101:103-110.
41. Harnett PR, Kearsley JH, Hayward NK, et al. Loss of allelic heterozygosity on distal chromosome 1p in Merkel cell carcinoma. A marker of neural crest origins? Cancer Genet Cytogenet. 1991;54:109-113.
42. Vortmeyer AO, Merino MJ, Boni R, et al. Genetic changes associated with primary Merkel cell carcinoma. Am J Clin Pathol. 1998;109:565-570.
43. Orsetti B, Nugoli M, Cervera N, et al. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Br J Cancer. 2006;20:95:1439-1447.
44. Courjal F, Theillet C. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res. 1997;57:4368-4377.
45. Schwab M, Praml C, Amler LC. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer. 1996;16:211-229.
46. Syversen U, Halvorsen T, Marvik R, et al. Neuroendocrine differentiation in colorectal carcinomas. Eur J Gastroenterol Hepatol. 1995;48:754-758.
47. Di Vinci A, Infusini E, Peveri C, et al. Deletions at chromosome 1p by fluorescence in situ hybridization are an early event in human colorectal tumorigenesis. Gastroenterology. 1996;111:102-107.
48. Lothe RA, Andersen SN, Hostad B, et al. Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosomes Cancer. 1995;14:182-188.
49. Henderson LJ, Coe BP, Lee EH, et al. Genomic and gene expression profiling of minute alterations of chromosome arm 1q in small cell lung carcinoma cells. Br J Cancer. 2005;92:1553-1560.
50. Bale SH, Dracopoli NC, Tucker MA, et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med. 1989;320:1367-1372.
51. Fong CT, Dracopoli NC, White PS, et al. Loss of heterozygosity for chromosome 1p in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci U S A. 1989;86:3753-3757.
52. Khosla S, Patel VM, Hay ID, et al. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest. 1991;87:1691-1699.
53. Gibas Z, Weil S, Chen ST, et al. Deletion of chromosome arm 1p in a Merkel cell carcinoma (MCC). Genes Chromosomes Cancer. 1994;9:216-220.
54. Van Gele M, Van Roy N, Ronan SG, et al. Molecular analysis of 1p36 breakpoints in two Merkel cell carcinomas. Genes Chromosomes Cancer. 1998;23:67-71.
55. Kennedy MM, Blessing K, King G, et al. Expression of bcl-2 and p53 in Merkel cell carcinoma. An immunohistochemical study. Am J Dermatopathol. 1996;18:273-277.
56. Schmid M, Janssen K, Dockhorn-Dworniczak B, et al. p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin: an immunohistochemical and SSCP analysis Virchows Arch. 1997;430:233-237.
57. Carson HJ, Reddy VJ, Taxy JB. Proliferation markers and prognosis in Merkel cell carcinoma. J Cutan Pathol. 1998;25:16-19.
58. Amo-Takyi BK, Tietze L, Tory K, et al. Diagnostic relevance of chromosomal in-situ hybridization in Merkel cell carcinoma: targeted interphase cytogenetic tumour analyses. Histopathology. 1999;34:163-169.
59. Akhtar S, Oza KK, Wright J. Merkel cell carcinoma: report of 10 cases and review of the literature. J Am Acad Dermatol. 2000;43:755-767.
60. Ott MJ, Tanabe KK, Gadd MA, et al. Multimodality management of Merkel cell carcinoma. Arch Surg. 1999;134:388-393.
61. Eng TY, Boersma MG, Fuller CD, et al. Treatment of Merkel cell carcinoma. Am J Clin Oncol. 2004;27:510-515.
62. Pitale M, Sessions RB, Husain S. An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope. 1992;102:244-249.
63. Tanaka K, Hiraiwa N, Hashimoto H, et al. Tenascin-C regulates angiogenesis in tumors through the regulation of vascular endothelial growth factor expression. Int J Cancer. 2004;108:31-40.
64. Koljonen V, Jahkola T, et al. Tenascin-C in primary Merkel cell carcinoma. J Clin Pathol. 2005;58:297-300.
65. Koljonen V, Bohling T, Tukiainen E, et al. Tenascin-C expression in Merkel cell carcinoma lymph node metastasis. APMIS. 2006;114:39-42.
66. Fernandez-Figueras MT, Puig L, Musulen E, et al. Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma. Histopathology. 2005;46:614-621.
67. Koljonen V, Tukiainen E, Haglund C, et al. Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma. Histopathology. 2006;49:551-553.
68. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89:1-4.
69. Medina-Franco H, Urist MM, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol. 2001;8:204-208.
70. Vandeput JJ, Kerre S, Vandepitte J, et al. Lymphangiectomy and treatment modalities in Merkel cell carcinoma: a report of five new cases. Anticancer Res. 1996;16:3887-3893.
71. Brissett AE, Olsen KD, Kasperbauer JL, et al. Merkel cell carcinoma of the head and neck: a retrospective case series. Head Neck. 2002;24:982-988.
72. Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg. 2001;127:149-154.
73. Lawenda BD, Thiringer JK, Foss RD, et al. Merkel cell carcinoma arising in the head and neck: optimizing therapy. Am J Clin Oncol. 2001;24:35-42.
74. Dolezal RF, Cohen M, Taxy JB. Merkel tumor of the lower lip: a case report and updated review of the literature work performed at the University of Illinois. J Surg Oncol. 1988;37:123-127.
75. Park GC, Shelton JB Jr, Ow RA, et al. Merkel cell carcinoma of the lower lip: a case report and histopathologic study. Arch Otolaryngol Head Neck Surg. 1999;125:907-911.
76. Hamilton J, Levine MR, Lash R, et al. Merkel cell carcinoma of the eyelid. Ophthalmic Surg. 1993;24:764-769.
77. Ferrau F, Micali G, Guitart J. Merkel cell carcinoma of the scalp: dramatic resolution with primary chemotherapy. J Am Acad Dermatol. 1994;31:271-272.
78. Stone N, Burge S. Guess What!Cutaneous Merkel cell carcinoma of the left lower leg. Eur J Dermatol. 1998;8:285-286.
79. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol. 2002;20:588-598.
80. Poulsen M. Merkel cell carcinoma of skin: diagnosis and management strategies. Drugs Aging. 2005;22:219-229.
81. Schwartz R, Clark W. Commentary the Merkel cell carcinoma: a 50-year retrospect. J Surg Oncol. 2005;89:5.
82. Savage P, Constenla D, Fisher C, et al. The natural history and management of Merkel cell carcinoma of the skin: a review of 22 patients treated at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol). 1997;9:164-167.
83. Dancey AL, Rayatt SS, Soon C, et al. Merkel cell carcinoma: a report of 34 cases and literature review. J Plast Reconstr Aesthet Surg. 2006;59:1294-1299.
84. Coleman NM, Smith-Zagone MJ, Tanyi J, et al. Primary neuroendocrine carcinoma of the vagina with Merkel cell carcinoma phenotype. Am J Surg Pathol. 2006;30:405-410.
85. Skarin AT. Merkel cell carcinoma. In: Atlas of Diagnostic Oncology. 2nd ed. St. Louis: Mosby Wolfe Pub; 1996:383
86. Leibovitch I, Davis G, Huilgol SC, et al. An unusual presentation of periocular Merkel cell carcinoma. J Cutan Pathol. 2006;33(suppl 2):39-41.
87. Palma S, Cavazzini L, Bovo R, et al. Merkel cell tumor of the external ear. Report of a case. Auris Nasus Larynx. 2007;34:229-232.
88. Khoury-Collado F, Elliott KS, Lee YC, et al. Merkel cell carcinoma of the Bartholin's gland. Gynecol Oncol. 2005;97:928-931.
89. Yom SS, Rosenthal DI, Adel K, et al. Merkel cell carcinoma of the tongue and head and neck oral mucosal sites. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:761-768.
90. Connelly TJ, Cribier B, Brown TJ, et al. Complete spontaneous regression of Merkel cell carcinoma: a review of the 10 reported cases. Dermatol Surg. 2000;26:853-856.
91. Inoue T, Yoneda K, Manabe M, et al. Spontaneous regression of Merkel cell carcinoma: a comparative study of TUNEL index and tumor-infiltrating lymphocytes between spontaneous regression and non-regression group. J Dermatol Sci. 2000;24:203-211.
92. Junquera L, Torre A, Vicente JC, et al. Complete spontaneous regression of Merkel cell carcinoma. Ann Otol Rhinol Laryngol. 2005;114:376-380.
93. Sais G, Admella C, Soler T. Spontaneous regression in primary cutaneous neuroendocrine (Merkel cell) carcinoma: a rare immune phenomenon? J Eur Acad Dermatol Venereol. 2002;16:82-83.
94. Morrison WH, Peters LJ, Silva EG, et al. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys. 1990;19:583-591.
95. Pilotti S, Rilke F, Bartoli C, et al. Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma. J Clin Oncol. 1988;6:1863-1873.
96. Smith DE, Bielamowicz S, Kagan AR, et al. Cutaneous neuroendocrine (Merkel cell) carcinoma. A report of 35 cases. Am J Clin Oncol. 1995;18:199-203.
97. Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol. 2007;25:1043-1047.
98. Schwindl B, Meissner A, Giedl J, et al. Merkel cell carcinoma - a rarity in the urogenital tract. Onkologie. 2006;29:326-328.
99. Tummala MK, Hausner PF, McGuire WP, et al. Testis: a sanctuary site in Merkel cell carcinoma. J Clin Oncol. 2006;24:1008-1009.
100. Gleason JM, Kohler TS, Monga M. Merkel cell carcinoma metastatic to testis. Urology. 2006;67:423.e13-423.e14.
101. Conley M, Hawkins K, Ririe D. Complete heart block and cardiac tamponade secondary to Merkel cell carcinoma cardiac metastases. South Med J. 2006;99:74-78.
102. Ouellette JR, Woodyard L, Toth L, et al. Merkel cell carcinoma metastatic to the head of pancreas. JOP. 2004;5:92-96.
103. Chang DT, Mancuso AA, Riggs CE, et al. Merkel cell carcinoma of the skin with leptomeningeal metastases. Am J Otolaryngol. 2005;26:210-213.
104. Tam C, Turner P, McLean C, et al. Correspondence "Leukaemic" presentation of metastatic Merkel cell carcinoma. Br J Hematol. 2005;129:446.
105. Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg. 1995;21:669-683.
106. Heenan PJ, Cole JM, Spagnolo DV. Primary cutaneous neuroendocrine carcinoma (Merkel cell tumor). An adnexal epithelial neoplasm. Am J Dermatopathol. 1990;12:7-16.
107. Mackay B. Neuroendocrine (Merkel cell) carcinomas of the skin: an ultrastructural study of nine cases. Ultrastruct Pathol. 1981;2:1-9.
108. Sidhu GS, Chandra P, Cassai ND. Merkel cells, normal and neoplastic: an update. Ultrastruct Pathol. 2005;29:287-294.
109. Hallman JR, Shaw JA, Geisinger KR, et al. Cytomorphologic features of Merkel cell carcinoma in fine needle aspiration biopsies. A study of two atypical cases. Acta Cytol. 2000;44:185-193.
110. Leong AS, Phillips GE, Pieterse AS, et al. Criteria for the diagnosis of primary endocrine carcinoma of the skin (Merkel cell carcinoma). A histological, immunohistochemical and ultrastructural study of 13 cases. Pathology. 1986;18:393-399.
111. Skoog L, Schmitt FC, Tani E. Neuroendocrine (Merkel-cell) carcinoma of the skin: immunocytochemical and cytomorphologic analysis on fine-needle aspirates. Diagn Cytopathol. 1990;6:53-57.
112. Battifora H, Silva EG. The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, and oat cell carcinoma. Cancer. 1986;58:1040-1046.
113. Walsh NM. Primary neuroendocrine (Merkel cell) carcinoma of the skin: morphologic diversity and implication thereof. Hum Pathol. 2001;32:680-689.
114. Green WR, Linnoila RI, Triche TJ. Neuroendocrine carcinoma of skin with simultaneous cytokeratin expression. Ultrastruct Pathol. 1984;6:141-152.
115. Acebo E, Vidaurrazaga N, Varas C, et al. Merkel cell carcinoma: a clinicopathological study of 11 cases. J Eur Acad Dermatol Venereol. 2005;19:546-551.
116. Bobos M. Immunohistochemical distinction between Merkel cell carcinoma and small cell carcinoma of the lung. Am J Dermatopathol. 2006;28:99-104.
117. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962-972.
118. Gould VE, Lee I, Hammar SP. Neuroendocrine skin carcinoma coexpressing cytokeratin and neurofilament proteins. Ultrastruct Pathol. 1985;9:83-90.
119. Gu J, Polak JM, Van Noorden S, et al. Immunostaining of neuronspecific enolase as a diagnostic tool for Merkel cell tumors. Cancer. 1983;52:1039-1043.
120. Legier JF. Value of cytokeratin 20 stain in Merkel-cell carcinoma. Diagn Cytopathol. 1998;19:472.
121. Scott MP, Helm KF. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol. 1999;21:16-20.
122. Yiengpruksawan A, Coit DG, Thaler HT, et al. Merkel cell carcinoma: prognosis and management. Arch Surg. 1991;126:1514-1519.
123. Cirillo F, Buononato M, Lima G, et al. Clinical experience on eight cases of Merkel cell carcinoma. Tumori. 2003;89:146-151.
124. Eich HT, Eich D, Staar S, et al. Role of postoperative radiotherapy in the management of Merkel cell carcinoma. Am J Clin Oncol. 2002;25:50-56.
125. Hohaus K, Kostler E, Schonlebe J, et al. Merkel cell carcinoma - a retrospective analysis of 17 cases. J Eur Acad Dermatol Venereol. 2003;17:20-24.
126. Samonis G, Mantadakis E, Kononas TC, et al. Merkel cell carcinoma: a case series of 12 patients and review of the literature. Anticancer Res. 2001;21:4173-4177.
127. Tai PT, Yu E, Winquist E, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol. 2000;18:2493-2499.
128. Anderson S, Beer K, Banic A, et al. MRI of Merkel cell carcinoma: histologic correlation and review of the literature. AJR Am J Roentgenol. 2005;185:1441-1448.
129. Iagaru A, Quon A, McDougall IR, et al. Merkel cell carcinoma: is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography? Mol Imaging Biol. 2006;8:212-217.
130. Belhocine T, Pierard GE, Fruhling J, et al. Clinical added-value of 18FDG PET in neuroendocrine-Merkel cell carcinoma. Oncol Rep. 2006;16:347-352.
131. Balkissoon J, Rasgon BM, Schweitzer L. Lymphatic mapping for staging of head and neck cancer. Semin Oncol. 2004;31:382-393.
132. Gipponi M, Solari N, Di Somma FC, et al. New fields of application of the sentinel lymph node biopsy in the pathologic staging of solid neoplasms: review of literature and surgical perspectives. J Surg Oncol. 2004;85:171-179.
133. Koops HS, Doting MH, deVries J, et al. Sentinel node biopsy as a surgical staging method for solid cancers. Radiother Oncol. 1999;51:1-7.
134. Sian KU, Wagner JD, Sood R, et al. Lymphoscintigraphy with sentinel lymph node biopsy in cutaneous Merkel cell carcinoma. Ann Plast Surg. 1999;42:679-682.
135. Zeitouni NC, Cheney RT, Delacure MD. Lymphoscintigraphy, sentinel lymph node biopsy, and Mohs micrographic surgery in the treatment of Merkel cell carcinoma. Dermatol Surg. 2000;26:12-18.
136. Alex JC. The application of sentinel node radiolocalization to solid tumors of the head and neck: a 10-year experience. Laryngoscope. 2004;114:2-19.
137. Blom A, Kolb F, Lumbroso J, et al. Significance of sentinel lymph node biopsy in Merkel cell carcinoma. Analysis of 11 cases. Ann Dermatol Venereol. 2003;130:417-422.
138. Maza S, Trefzer U, Hofmann M, et al. Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging. 2006;33:433-440.
139. Allen PJ, Busam K, Hill AD, et al. Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer. 2001;92:1650-1655.
140. Gupta SG, Wang LC, Penas PF, et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol. 2006;142:685-690.
141. Hill AD, Brady MS, Coit DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg. 1999;86:518-521.
142. Mehrany K, Otley CC, Weenig RH, et al. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg. 2002;28:113-117; discussion 117.
143. Messina JL, Reintgen DS, Cruse CW, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 1997;4:389-395.
144. Civantos FJ, Moffat FL, Goodwin WJ. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope. 2006;112(3 Pt 2 suppl 109):1-15.
145. Stadelmann WK, Cobbins L, Lentsch EJ. Incidence of nonlocalization of sentinel lymph nodes using preoperative lymphoscintigraphy in 74 consecutive head and neck melanoma and Merkel cell carcinoma patients. Ann Plast Surg. 2004;52:546-549; discussion 550.
146. Wasserberg N, Schachter J, Fenig E, et al. Applicability of the sentinel node technique to Merkel cell carcinoma. Dermatol Surg. 2000;26:138-141.
147. Duker I, Starz H, Bachter D, et al. Prognostic and therapeutic implications of sentinel lymphonodectomy and S-staging in Merkel cell carcinoma. Dermatology. 2001;202:225-229.
148. Rodrigues LK, Leong SP, Kashani-Sabet M, et al. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Dermatol. 2001;45:303-308.
149. Allen PJ, Zahan ZF, Coit DG. The surgical management of Merkel cell carcinoma. Ann Surg. 1999;229:97-105.
150. Allen PJ, Bowne WB, Jacques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300-2309.
151. Fenig E, Brenner B, Katz A, et al. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer. 1997;80:881-885.
152. Poulsen M, Rischin D, Walpole E, et al. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study - TROG 96:07. J Clin Oncol. 2003;21:4371-4376.
153. Shaw JH, Rumball E. Merkel cell tumour: clinical behaviour and treatment. Br J Surg. 1991;78:138-142.
154. Coit DG. Merkel cell carcinoma. Ann Surg Oncol. 2001;8(9 suppl):99S-102S.
155. Sandel HD IV, Day T, Richardson MS, et al. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival? Laryngoscope. 2006;116:791-795.
156. Skelton HG, Smith KJ, Hitchcock CL, et al. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol. 1997;37:734-739.
157. Llombart B, Monteagudo C, Lopez-Guerrero JA, et al. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology. 2005;46:622-634.
158. Lewis KG, Weinstock MA, Weaver AL, et al. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol. 2006;142:693-700. Comment in: 2006;142:771-774.
159. Greenfield LJ, Mulholland MW, Oldham KT, et al. Greenfield's Surgery: Scientific Principles and Practice. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2005.
160. Phillips TW, Abdel-Wahab M. Merkel cell tumor: a review of the literature. J Med Assoc Ga. 1990;79:253-254.
161. Al-Ghazal SK, Arora DS, Simpson RH, et al. Merkel cell carcinoma of the skin. Br J Plast Surg. 1996;49:491-496.
162. Bischof M, van Kampen M, Huber P, et al. Merkel cell carcinoma: the role of radiation therapy in general management. Strahlenther Onkol. 1999;175:611-615.
163. Marks ME, Kim RY, Salter MM. Radiotherapy as an adjunct in the management of Merkel cell carcinoma. Cancer. 1990;65:60-64.
164. Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:325-331.
165. Shack RB, Barton RM, DeLozier J, et al. Is aggressive surgical management justified in the treatment of Merkel cell carcinoma? Plast Reconstr Surg. 1994;94:970-975.
166. Wilder RB, Harari PM, Graham AR, et al. Merkel cell carcinoma. Improved locoregional control with postoperative radiation therapy. Cancer. 1991;68:1004-1008.
167. Wong KC, Zuletta F, Clarke SJ, et al. Clinical management and treatment outcomes of Merkel cell carcinoma. Aust N Z J Surg. 1998;68:354-358.
168. Westgate SJ. Radiation therapy for skin tumors. Otolaryngol Clin North Am. 1993;26:295-309.
169. Mortier L, Mirabel X, Fournier C, et al. Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol. 2003;139:1587-1590.
170. Boyer JD, Zitelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol. 2002;47:885-892.
171. McAfee WJ, Morris CG, Mendenhall CM, et al. Merkel cell carcinoma: treatment and outcomes. Cancer. 2005;104:1761-1764.
172. Veness MJ, Perera L, McCourt J, et al. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ J Surg. 2005;75:275-281.
173. Brady MS. Current management of patients with Merkel cell carcinoma. Dermatol Surg. 2004;30(2 Pt 2):321-325.
174. Suarez C, Rodrigo JP, Ferlito A, et al. Merkel cell carcinoma of the head and neck. Oral Oncol. 2004;40:773-779.
175. Veness MJ. Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): an overview of management. Australas J Dermatol. 2006;47:160-165.
176. Senchenkov A, Barnes SA, Moran SL. Predictors of survival and recurrence in the surgical treatment of Merkel cell carcinoma of the extremities. J Surg Oncol. 2007;95:229-234.
177. Victor S, Morton B, Smith J. Merkel cell carcinoma: is prophylactic lymph node dissection indicated? Am Surg. 62:1996;879-882.
178. Pacella J, Ashby M, Ainslie J, et al. The role of radiotherapy in the management of primary cutaneous neuroendocrine tumors (Merkel cell or trabecular carcinoma): experience at the Peter MacCallum Cancer Institute (Melbourne, Australia). Int J Radiat Oncol Biol Phys. 1988;14:1077-1084.
179. Leong SP. Selective sentinel lymphadenectomy for malignant melanoma, Merkel cell carcinoma, and squamous cell carcinoma. Cancer Treat Res. 2005;127:39-76.
180. Kurul S, Mudun A, Aksakal N, et al. Lymphatic mapping for Merkel cell carcinoma. Plast Reconstr Surg. 2000;46:467-474.
181. Poulsen M, Harvey J. Is there a diminishing role for surgery for Merkel cell carcinoma of the skin? A review of current management. ANZ J Surg. 2002;72:142-146.
182. Wilson LD, Gruber SB. Merkel cell carcinoma and the controversial role of adjuvant radiation therapy: clinical choices in the absence of statistical evidence. J Am Acad Dermatol. 2004;50:435-437; discussion 437-438.
183. O'Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in 86 patients. Dermatol Surg. 1997;23:929-933.
184. Leonard JH, Bell JR. Insights into the Merkel cell phenotype from Merkel cell carcinoma cell lines. Australas J Dermatol. 1997;38(suppl 1):S91-S98.
185. Leonard JH, Ramsay JR, Kearsley JH, et al. Radiation sensitivity of Merkel cell carcinoma cell lines. Int J Radiat Oncol Biol Phys. 1995;32:1401-1407.
186. Cotlar AM, Gates JO, Gibbs FA Jr. Merkel cell carcinoma: combined surgery and radiation therapy. Am Surg. 1986;52:159-164.
187. O'Brien PC, Denham JW, Leong AS. Merkel cell carcinoma: a review of behaviour patterns and management strategies. Aust N Z J Surg. 1987;57:847-850.
188. Rice RD Jr, Chonkich GD, Thompson KS, et al. Merkel cell tumor of the head and neck. Five new cases with literature review. Arch Otolaryngol Head Neck Surg. 1993;119:782-786.
189. NCCN Clinical Practice Guidelines in Oncology - Merkel cell carcinoma. J Natl Compr Cancer Netw. 2007;1.
190. Azagury M, Chevallier B, Atlan D, et al. VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remission. Am J Clin Oncol. 1993;16:102-104.
191. Davis MP, Miller EM, Rau RC, et al. The use of VP16 and cisplatin in the treatment of Merkel cell carcinoma. J Dermatol Surg Oncol. 1990;16:276-278.
192. George TK, di Sant'agnese PA, Bennett JM. Chemotherapy for metastatic Merkel cell carcinoma. Cancer. 1985;56:1034-1038.
193. Kokoska ER, Kokoska MS, Collins BT, et al. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg. 1997;174:688-693.
194. Kearsley JH, Hurst T, Khoo SK. Chemosensitivity testing of primary cultures of Merkel cell cancer. Anticancer Drugs. 1993;4:571-575.
195. Wynne CJ, Kearsley JH. Merkel cell tumor: a chemosensitive skin cancer. Cancer. 1998;62:28-31.
196. Feun LG, Savaraj N, Legha SS, et al. Chemotherapy for metastatic Merkel cell carcinoma: review of the M. D.Anderson Hospital's experience. Cancer. 1988;62:683-685.
197. Pectasides D, Pectasides M, Economopoulos T. Merkel cell cancer of the skin. Ann Oncol. 2006;17:1489-1495.
198. Pectasides D, Pectasides M, Psyrri A, et al. Cisplatin-based chemotherapy for Merkel cell carcinoma of the skin. Cancer Invest. 2006;24:780-785.
199. Voog E, Biron P, Martin JP, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer. 1999; 85:2589-2595.
200. Poulsen MG, Rischin D, Porter I, et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys. 2006;64:114-119.
201. Hata Y, Matsuka K, Ito O, et al. Two cases of Merkel cell carcinoma cured by intratumor injection of natural human tumor necrosis factor. Plast Reconstr Surg. 1997;99:547-553.
202. Su LD, Fullen DR, Lowe L, et al. CD117(KIT receptor) expression in Merkel cell carcinoma. Am J Dermatopathol. 2002;24:289-293.
203. Kondapalli L, Soltani K, Lacouture ME. The promise of molecular target therapies: protein kinase inhibitors in the treatment of cutaneous malignancies. J Am Acad Dermatol. 2005;53:291-302.
204. Waldmann V, Goldschmidt H, Jackel A, et al. Transient complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation. Br J Dermatol. 2000;143:837-839.
205. Grandpeix C, Bonvalot S, Petrow P, et al. Continued complete remission of Merkel cell carcinoma with intransit metastasis after treatment with isolated limb perfusion regional chemotherapy. Ann Dermatol Venereol. 2006;133:700-703.
206. Herrmann G, Groth W, Kreig T, et al. Complete remission of Merkel cell carcinoma of the scalp with local and regional metastases after topical treatment with dinitrochlorbenzol. J Am Acad Dermatol. 2004;50:965-969.